Use of monoclonal antibodies against the epidermal growth factor receptor in the treatment of patients with hypoxemic acute respiratory failure

The present invention relates to the fields of biotechnology and medicine and provides the use of monoclonal antibodies against the epidermal growth factor receptor in the treatment of diseases of infectious origin that leading to a hypoxemic acute respiratory failure.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEON MONZON, KALET, RAMOS SUZARTE, MAYRA, DIAZ LONDRES, HENRRY, SAAVEDRA HERNANDEZ, DANAY, ABDO CUZA, ANSELMO ANTONIO, ANE KOURI, ANA LAURA, CROMBET RAMOS, TANIA, PEREZ RODRIGUEZ, ROLANDO, JIMENEZ ARMADA, JORGE
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the fields of biotechnology and medicine and provides the use of monoclonal antibodies against the epidermal growth factor receptor in the treatment of diseases of infectious origin that leading to a hypoxemic acute respiratory failure.